MarketInOut Stock Screener Log In | Sign Up
 

Aura Biosciences Inc

NASDAQ • Healthcare • Biotechnology • Quote as of 09/11/2026
Aura Biosciences Inc stock price and volume chart

Company Profile

IndustryBiotechnology
SectorHealthcare
ExchangeNASDAQ
Market Capitalization725.42 mln
Float103 mln
Earnings Date11/05/2026

Piotroski F-Score

3 / 9
Below average

1-Year Forecast

16.60
Transformational upside

Relative Strength

17 / 100
Significantly lagging

Debt / Equity

0.05
Debt-free

ROE

-73.54
Deeply negative

ROA

-62.41
Deeply negative

Business Description

Aura Biosciences is a Boston-based clinical-stage company focused on developing targeted treatments for solid tumors. It uses a proprietary technology that attaches drugs or genetic material to virus-like particles, allowing them to seek out and attack cancer cells with greater precision. Its lead drug candidate, bel-sar, is being tested in advanced trials for eye melanoma and other eye cancers, as well as in earlier trials for bladder cancer.

Key Fundamentals

EPS-1.73
ROE-73.54
ROIC-493
ROA-62.41
EBITDA, mln-137
EV / EBITDA-3.36
EV / EBIT-3.33

Financial Strength

Piotroski F-Score 3 / 9
1-Year Target Price16.60
Short Ratio7.85
Short % of Float6.02

Price Performance & Relative Strength

Period Price Performance Relative Strength
1 Week -5.02% 20 / 100   
1 Month -9.68% 20 / 100   
2 Months 2.94% 71 / 100   
6 Months 17.65% 76 / 100   
1 Year 8.7% 57 / 100   



Disclaimer - Privacy Policy - Terms Of Service - Cookie Use Policy - FAQ - Contact Us